Elena Solfaroli Camillocci

TL;DR: Beta-particle radioguided tumor resection may potentially overcome the limitations of conventional gamma-ray guided surgery by eliminating, or at least minimizing, the confounding effect of counts contributed by activity in adjacent normal tissues by evaluating the clinical feasibility of this approach for a variety of radionuclides.

TL;DR: In this article, an effective and robust analysis to detect regions with a significant range discrepancy is proposed, which relies on in-vivo treatment verification by means of in-beam Positron Emission Tomography (PET) and was carried out with the INSIDE system installed at the National Centre of Oncological Hadrontherapy (CNAO) in Pavia, which is under clinical testing since July 2019.

TL;DR: Despite a high physiological uptake of 68Ga-DOTATOC in the healthy pancreas, the proposed RGS technique promises to be effective and allows RGS to find application also in pancreatic diseases, where traditional techniques are not viable.

TL;DR: In this article, the authors proposed a radio-guided surgery for brain tumours, where surgery is the only possible treatment and the assessment of the resection would most profit from the low background around the lesion.

TL;DR: In this paper, the authors presented a radio-guided surgery for brain tumor resection using the low background around the lesion, as for brain tumours, and the prototype under study has 70% efficiency on electrons with an energy threshold at 540 keV, a point-like resolution of 2.8±0.1 mm, and sensitivity to photons lower than 1%.